MILAN, Italy, May 16, 2006 – Dompé pha.r.ma s.p.a. and Axxam s.r.l. announced today a research collaboration for the discovery and development of novel drugs based on GPCR targets. “The partnership between Dompé pha.r.ma and Axxam brings together the know-how and expertise of each company in drug discovery and development,” said Sergio Dompé, President of the Holding Company Dompé Farmaceutici. “We believe that by combining our excellence in product research and development we will increase the likelihood and speed of discovering and developing new therapeutics for patients.”
For more information, please visit: www.dompe.it
